Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 188

    1.

    Prospective study of hyperglycemia and cancer risk.

    Stattin P, Björ O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R.

    Diabetes Care. 2007 Mar;30(3):561-7.PMID: 17327321 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fasting serum glucose level and cancer risk in Korean men and women.

    Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM.

    JAMA. 2005 Jan 12;293(2):194-202.PMID: 15644546 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort.

    Furberg AS, Thune I.

    Int J Cancer. 2003 May 10;104(6):669-76. Erratum in: Int J Cancer. 2003 May 10;104(6):799. PMID: 12640672 [PubMed - indexed for MEDLINE]Related articles

    4.

    Fasting glucose is a risk factor for breast cancer: a prospective study.

    Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F.

    Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1361-8.PMID: 12433712 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Abnormal glucose metabolism and pancreatic cancer mortality.

    Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A.

    JAMA. 2000 May 17;283(19):2552-8.PMID: 10815119 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort.

    Lukanova A, Björ O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P.

    Int J Cancer. 2006 Jan 15;118(2):458-66.PMID: 16049963 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

    Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjønneland A, Olsen A, Overvad K, Jakobsen MU, Chajès V, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Lukanova A, Boeing H, Pischon T, Trichopoulou A, Christina B, Trichopoulos D, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Gram IT, Lund E, Quirós JR, Travier N, Martínez-García C, Larrañaga N, Chirlaque MD, Ardanaz E, Berglund G, Lundin E, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Bingham S, Khaw KT, Allen N, Key T, Ferrari P, Rinaldi S, Slimani N, Riboli E.

    Endocr Relat Cancer. 2007 Sep;14(3):755-67.PMID: 17914105 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The association between hyperglycemia and fracture risk in middle age. A prospective, population-based study of 22,444 men and 10,902 women.

    Holmberg AH, Nilsson PM, Nilsson JA, Akesson K.

    J Clin Endocrinol Metab. 2008 Mar;93(3):815-22. Epub 2007 Dec 11.PMID: 18073298 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.

    Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quirós JR, Agudo A, Sánchez MJ, Larrañaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R.

    Int J Cancer. 2007 Jun 15;120(12):2656-64.PMID: 17285578 [PubMed - indexed for MEDLINE]Related articles

    10.

    Postload plasma glucose concentration and 27-year prostate cancer mortality (United States).

    Gapstur SM, Gann PH, Colangelo LA, Barron-Simpson R, Kopp P, Dyer A, Liu K.

    Cancer Causes Control. 2001 Oct;12(8):763-72.PMID: 11562117 [PubMed - indexed for MEDLINE]Related articles

    11.

    Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.

    Chiu BC, Gapstur SM, Greenland P, Wang R, Dyer A.

    Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2348-54.PMID: 17164355 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Obesity, weight gain, and the risk of kidney stones.

    Taylor EN, Stampfer MJ, Curhan GC.

    JAMA. 2005 Jan 26;293(4):455-62.PMID: 15671430 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Physical activity, obesity, height, and the risk of pancreatic cancer.

    Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS.

    JAMA. 2001 Aug 22-29;286(8):921-9.PMID: 11509056 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Relation of body mass index to cancer risk in 362,552 Swedish men.

    Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr.

    Cancer Causes Control. 2006 Sep;17(7):901-9.PMID: 16841257 [PubMed - indexed for MEDLINE]Related articles

    15.

    Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study.

    Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J.

    Diabetes Care. 1997 Feb;20(2):163-9.PMID: 9118765 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study.

    Berrington de Gonzalez A, Yun JE, Lee SY, Klein AP, Jee SH.

    Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):359-64.PMID: 18268120 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study.

    de Vegt F, Dekker JM, Ruhé HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

    Diabetologia. 1999 Aug;42(8):926-31.PMID: 10491751 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased blood glucose and insulin, body size, and incident colorectal cancer.

    Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ.

    J Natl Cancer Inst. 1999 Jul 7;91(13):1147-54.PMID: 10393723 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project.

    Manjer J, Kaaks R, Riboli E, Berglund G.

    Eur J Cancer Prev. 2001 Feb;10(1):33-42.PMID: 11263589 [PubMed - indexed for MEDLINE]Related articles